MRK vs ZBH
By Alex · Tickerpine
Merck & Company, Inc. vs Zimmer Biomet Holdings, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | ZBH |
|---|---|---|
| Price | $132.92 | $97.89 |
| Market cap | $327.94B | $18.67B |
| P/E ratio | 106.3 | 23.6 |
| ROE | 6.96% | 6.41% |
| Profit margin | 4.77% | 9.48% |
| Revenue growth | 5.10% | 4.80% |
| Dividend yield | 2.56% | 0.98% |
| Beta | 0.21 | 0.46 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs ZBH in plain English
- MRK is the bigger company — about 17.6× the market cap of ZBH.
- ZBH is cheaper on earnings (P/E 23.6 vs 106.3).
- MRK earns a higher return on equity (7% vs 6%).
- MRK is growing revenue faster (5% vs 5%).
- MRK has the higher dividend yield (2.56% vs 0.98%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Company, Inc. would be worth today.
ZBH return calculator
See what $1,000 in Zimmer Biomet Holdings, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.